Cellares and TScan Therapeutics Partner to Evaluate Automated Manufacturing of TSC-101 for Hematologic Malignancies

Cellares and TScan Therapeutics Collaborate to Evaluate Automated Manufacturing for TSC-101 TCR-T Therapy in AML and MDS Cellares, the first Integrated Development and Manufacturing Organization (IDMO), and TScan Therapeutics, Inc.…

Read MoreCellares and TScan Therapeutics Partner to Evaluate Automated Manufacturing of TSC-101 for Hematologic Malignancies